coronary trial
BMS Jettisons Coronary Trial for J&J-Partnered Anticoagulant
Bristol Myers Squibb; Johnson & Johnson; Janssen; anticoagulant; Factor XIa inhibitor; BMS-986177; coronary trial; clinical trial termination
Actionable Insights Powered by AI
Bristol Myers Squibb; Johnson & Johnson; Janssen; anticoagulant; Factor XIa inhibitor; BMS-986177; coronary trial; clinical trial termination